133 related articles for article (PubMed ID: 20919968)
1. Invasive pneumococcal disease in non-Indigenous people in north Queensland, 2001-2009.
Hanna JN; Humphreys JL; Murphy DM; Smith HV
Med J Aust; 2010 Oct; 193(7):392-6. PubMed ID: 20919968
[TBL] [Abstract][Full Text] [Related]
2. Invasive pneumococcal disease in Indigenous people in north Queensland: an update, 2005-2007.
Hanna JN; Humphreys JL; Murphy DM
Med J Aust; 2008 Jul; 189(1):43-6. PubMed ID: 18601643
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of impact of 23 valent pneumococcal polysaccharide vaccine following 7 valent pneumococcal conjugate vaccine in Australian Indigenous children.
Jayasinghe S; Chiu C; Menzies R; Lehmann D; Cook H; Giele C; Krause V; McIntyre P
Vaccine; 2015 Nov; 33(48):6666-74. PubMed ID: 26519550
[TBL] [Abstract][Full Text] [Related]
4. Pneumococcal disease in South Australia: vaccine success but no time for complacency.
Johnson DR; D'Onise K; Holland RA; Raupach JC; Koehler AP
Vaccine; 2012 Mar; 30(12):2206-11. PubMed ID: 22273663
[TBL] [Abstract][Full Text] [Related]
5. Invasive pneumococcal disease in Indigenous people in north Queensland, 1999-2004.
Hanna JN; Humphreys JL; Murphy DM
Med J Aust; 2006 Feb; 184(3):118-21. PubMed ID: 16460296
[TBL] [Abstract][Full Text] [Related]
6. Changing epidemiology of invasive pneumococcal disease in Australian children after introduction of a 7-valent pneumococcal conjugate vaccine.
Williams SR; Mernagh PJ; Lee MH; Tan JT
Med J Aust; 2011 Feb; 194(3):116-20. PubMed ID: 21299484
[TBL] [Abstract][Full Text] [Related]
7. The changing epidemiology of invasive pneumococcal disease in aboriginal and non-aboriginal western Australians from 1997 through 2007 and emergence of nonvaccine serotypes.
Lehmann D; Willis J; Moore HC; Giele C; Murphy D; Keil AD; Harrison C; Bayley K; Watson M; Richmond P
Clin Infect Dis; 2010 Jun; 50(11):1477-86. PubMed ID: 20420501
[TBL] [Abstract][Full Text] [Related]
8. High nasopharyngeal carriage of non-vaccine serotypes in Western Australian aboriginal people following 10 years of pneumococcal conjugate vaccination.
Collins DA; Hoskins A; Bowman J; Jones J; Stemberger NA; Richmond PC; Leach AJ; Lehmann D
PLoS One; 2013; 8(12):e82280. PubMed ID: 24349245
[TBL] [Abstract][Full Text] [Related]
9. Invasive pneumococcal disease in Australia, 2006.
Roche PW; Krause V; Cook H; Barralet J; Coleman D; Sweeny A; Fielding J; Giele C; Gilmour R; Holland R; Kampen R; ; Brown M; Gilbert L; Hogg G; Murphy D;
Commun Dis Intell Q Rep; 2008 Mar; 32(1):18-30. PubMed ID: 18522302
[TBL] [Abstract][Full Text] [Related]
10. The impact of the changing pneumococcal national immunisation program among older Australians.
Menzies R; Stein AN; Booy R; Van Buynder PG; Litt J; Cripps AW
Vaccine; 2021 Jan; 39(4):720-728. PubMed ID: 33384189
[TBL] [Abstract][Full Text] [Related]
11. Impact of pneumococcal polysaccharide vaccine in people aged 65 years or older.
Menzies RI; Jayasinghe SH; Krause VL; Chiu CK; McIntyre PB
Med J Aust; 2014 Feb; 200(2):112-5. PubMed ID: 24484116
[TBL] [Abstract][Full Text] [Related]
12. Invasive pneumococcal disease in Australia 2007 and 2008.
Barry C; Krause VL; Cook HM; Menzies RI
Commun Dis Intell Q Rep; 2012 Jun; 36(2):E151-65. PubMed ID: 23186214
[TBL] [Abstract][Full Text] [Related]
13. Invasive pneumococcal disease in Australia, 2004.
Roche PW; Krause VL; Bartlett M; Coleman D; Cook H; Davis C; Fielding JE; Holland R; Giele C; Gilmour R; Kampen R; Brown M; Gilbert L; Hogg G; Murphy D;
Commun Dis Intell Q Rep; 2006; 30(1):80-92. PubMed ID: 16637236
[TBL] [Abstract][Full Text] [Related]
14. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF
Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490
[TBL] [Abstract][Full Text] [Related]
15. Forecasting invasive pneumococcal disease trends after the introduction of 13-valent pneumococcal conjugate vaccine in the United States, 2010-2020.
Link-Gelles R; Taylor T; Moore MR;
Vaccine; 2013 May; 31(22):2572-7. PubMed ID: 23583813
[TBL] [Abstract][Full Text] [Related]
16. Invasive pneumococcal disease in Australia, 2005.
Roche P; Krause V; Cook H; Bartlett M; Coleman D; Davis C; Fielding J; Giele C; Gilmour R; Holland R; Kampen R;
Commun Dis Intell Q Rep; 2007 Mar; 31(1):86-100. PubMed ID: 17503648
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of the seven-valent and thirteen-valent pneumococcal conjugate vaccines in England: The indirect cohort design, 2006-2018.
Andrews N; Kent A; Amin-Chowdhury Z; Sheppard C; Fry N; Ramsay M; Ladhani SN
Vaccine; 2019 Jul; 37(32):4491-4498. PubMed ID: 31272872
[TBL] [Abstract][Full Text] [Related]
18. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.
Naidu L; Chiu C; Habig A; Lowbridge C; Jayasinghe S; Wang H; McIntyre P; Menzies R
Commun Dis Intell Q Rep; 2013 Dec; 37 Suppl():S1-95. PubMed ID: 24410428
[TBL] [Abstract][Full Text] [Related]
19. Laboratory surveillance of invasive pneumococcal disease in Australia in 2001 to 2002--implications for vaccine serotype coverage.
Watson M; Bayley K; Bell JM; Gilbert GL; Hogg G; Keil AD; Krause V; Murphy D; Roche P; Smith HV; Stewart MG; Stylianopoulos J; Turnidge J
Commun Dis Intell Q Rep; 2003; 27(4):478-87. PubMed ID: 15508501
[TBL] [Abstract][Full Text] [Related]
20. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
Jayasinghe S; Menzies R; Chiu C; Toms C; Blyth CC; Krause V; McIntyre P
Clin Infect Dis; 2017 Jan; 64(2):175-183. PubMed ID: 27986682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
